MacroCure Ltd. Report issue

For profit Phase 3
Founded: Petah Tiqva Israel (2008)
Status: Acquired by Leap Therapeutics, Inc. (2016)

Organization Overview

First Clinical Trial
2009
NCT01038986
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

curexcell (3 trials)

Drugs in Other Trials (1)

allogeneic blood cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leg Ulcer (Phase 3)

Ulcer (Phase 3)

Varicose Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 2